StockNews.com downgraded shares of Tactile Systems Technology (NASDAQ:TCMD – Free Report) from a strong-buy rating to a buy rating in a research note issued to investors on Monday morning.
TCMD has been the topic of a number of other research reports. BTIG Research downgraded shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating in a research note on Tuesday, November 5th. Oppenheimer downgraded shares of Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a report on Tuesday, November 5th. Finally, B. Riley initiated coverage on Tactile Systems Technology in a research note on Thursday, September 26th. They set a “buy” rating and a $23.00 price objective on the stock.
Read Our Latest Stock Report on Tactile Systems Technology
Tactile Systems Technology Stock Performance
Institutional Investors Weigh In On Tactile Systems Technology
Institutional investors and hedge funds have recently modified their holdings of the business. Tidal Investments LLC boosted its position in Tactile Systems Technology by 20.9% in the 3rd quarter. Tidal Investments LLC now owns 25,957 shares of the company’s stock valued at $379,000 after buying an additional 4,483 shares during the period. Barclays PLC boosted its holdings in shares of Tactile Systems Technology by 56.7% in the third quarter. Barclays PLC now owns 66,885 shares of the company’s stock valued at $977,000 after purchasing an additional 24,188 shares during the period. Hohimer Wealth Management LLC purchased a new stake in shares of Tactile Systems Technology in the third quarter valued at approximately $320,000. Geode Capital Management LLC grew its stake in Tactile Systems Technology by 1.5% in the third quarter. Geode Capital Management LLC now owns 558,667 shares of the company’s stock worth $8,164,000 after purchasing an additional 8,422 shares in the last quarter. Finally, XTX Topco Ltd purchased a new position in Tactile Systems Technology during the 3rd quarter worth $163,000. 83.43% of the stock is owned by institutional investors.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Featured Stories
- Five stocks we like better than Tactile Systems Technology
- The Significance of Brokerage Rankings in Stock Selection
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Are Trending Stocks? Trending Stocks Explained
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What Are Dividend Challengers?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.